Table I.
Cytotoxic and Antitumor Activity of Taxol (1)
Cytotoxic Activity
| ||
---|---|---|
KB (human carcinoma of the nasopharynx): | ||
ED50 =3.5 × 10−5 μg/mL | ||
(ED50 = conc. required for 50% inhibition of growth) | ||
Antitumor Activity
| ||
System Tested | Administration | Activity (% T/C) |
i.p P388 Leukemia | i.p. | + (164) |
i.p. B16 Melanoma | i.p. | ++ (283) |
i.p. L1210 Leukemia | i.p. | + (139) |
S.R.C* CX-1 Colon Xenograft | s.c. | ++ (3) |
S.R.C. LX- Lung Xenograft | s.c. | + (8) |
S.R.C. MX-1 Mammary Xenograft | s.c. | ++ (−77) |
Sub-renal capsule